These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34910777)

  • 1. Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.
    Kositpantawong N; Surasombatpattana S; Siripaitoon P; Kanchanasuwan S; Hortiwakul T; Charernmak B; Nwabor OF; Chusri S
    PLoS One; 2021; 16(12):e0261411. PubMed ID: 34910777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.
    Sharma Y; Horwood C; Hakendorf P; Thompson C
    Int J Infect Dis; 2021 Mar; 104():232-238. PubMed ID: 33434667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Study Evaluating the Effectiveness of Oseltamivir Initiated at the Time of Hospital Admission in Adults Hospitalized With Influenza-Associated Lower Respiratory Tract Infections.
    Ramirez J; Peyrani P; Wiemken T; Chaves SS; Fry AM
    Clin Infect Dis; 2018 Aug; 67(5):736-742. PubMed ID: 29659754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
    Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
    J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.
    Groeneveld GH; Marbus SD; Ismail N; de Vries JJC; Schneeberger P; Oosterheert JJ; van Dissel JT; de Boer MGJ
    Int J Antimicrob Agents; 2020 Nov; 56(5):106155. PubMed ID: 32898685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.
    Alghanem AF; Aldhahri FA; Althemery AU
    Saudi Med J; 2021 Oct; 42(10):1072-1077. PubMed ID: 34611001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
    Blumentals WA; Schulman KL
    Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
    Coffin SE; Leckerman K; Keren R; Hall M; Localio R; Zaoutis TE
    Pediatr Infect Dis J; 2011 Nov; 30(11):962-6. PubMed ID: 21997661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
    Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
    Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.
    Wilkes JJ; Zaoutis TE; Keren R; Desai B; Leckerman KH; Hodinka RL; Metjian TA; Coffin SE
    J Hosp Med; 2009 Mar; 4(3):171-8. PubMed ID: 19301375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
    Deshpande A; Klompas M; Yu PC; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
    Chest; 2022 Sep; 162(3):543-555. PubMed ID: 35134384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international perspective on hospitalized patients with viral community-acquired pneumonia.
    Radovanovic D; Sotgiu G; Jankovic M; Mahesh PA; Marcos PJ; Abdalla MI; Di Pasquale MF; Gramegna A; Terraneo S; Blasi F; Santus P; Aliberti S; Reyes LF; Restrepo MI;
    Eur J Intern Med; 2019 Feb; 60():54-70. PubMed ID: 30401576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy assessment of antiviral alone and antiviral-antibiotic combination in prevention of influenza-B infection associated complications.
    Ishaqui A; Hayat Khan A; Sulaiman SAS; Taher Alsultan M; Khan I
    Expert Rev Anti Infect Ther; 2021 Sep; 19(9):1165-1173. PubMed ID: 33567928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Hung IFN; To KKW; Chan JFW; Cheng VCC; Liu KSH; Tam A; Chan TC; Zhang AJ; Li P; Wong TL; Zhang R; Cheung MKS; Leung W; Lau JYN; Fok M; Chen H; Chan KH; Yuen KY
    Chest; 2017 May; 151(5):1069-1080. PubMed ID: 27884765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.
    Peters PH; Moscona A; Schulman KL; Barr CE
    Medscape J Med; 2008 Jun; 10(6):131. PubMed ID: 18679536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.